Metabolic abnormalities in autosomal dominant polycystic kidney disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/ndt/gfu044PMID 24589722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autosomal dominant polycystic kidney disease.

  2014cited by this paper
• Title Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin.

  2013cited by this paper
• Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.

  2013cited by this paper
• New treatments for autosomal dominant polycystic kidney disease

  2013cited by this paper
• Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

  2013cited by this paper
• Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease.

  2013cited by this paper
• Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst.

  2012influential reference
• New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: A retrospective cohort study

  2012cited by this paper
• Pathway analysis of genome-wide association studies on uric acid concentrations.

  2012cited by this paper
• Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid

  2012cited by this paper
• Increased Na+/H+ exchanger activity on the apical surface of a cilium-deficient cortical collecting duct principal cell model of polycystic kidney disease.

  2012cited by this paper
• Transport, cilia, and PKD: must we in (cyst) on interrelationships? Focus on "Increased Na+/H+ exchanger activity on the apical surface of a cilium-deficient cortical collecting duct principal cell model of polycystic kidney disease".

  2012cited by this paper
• Hypophosphatemia in patients with autosomal dominant polycystic kidney disease: the role of fibroblast growth factor 23 or loss of sodium/phosphate cotransporter?

  2011cited by this paper
• Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

  2011influential reference
• Prevalence and determinants of anemia in the immediate postkidney transplant period

  2011cited by this paper
• Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.

  2011cited by this paper
• Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.

  2011cited by this paper
• Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.

  2011cited by this paper
• Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance Test

  2011cited by this paper
• Autosomal dominant polycystic kidney disease.

  2010cited by this paper
• Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models

  2010cited by this paper
• Lipids and renal cystic disease.

  2010cited by this paper
• Early renal abnormalities in autosomal dominant polycystic kidney disease.

  2010cited by this paper
• Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease

  2010cited by this paper
• Association of Metabolic Syndrome With Development of New-Onset Diabetes After Transplantation

  2010cited by this paper
• Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease

  2010cited by this paper
• Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1‐deficient mouse

  2009cited by this paper
• Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

  2009cited by this paper
• Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout

  2009cited by this paper
• Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study.

  2008cited by this paper
• Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease.

  2008cited by this paper
• Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

  2007cited by this paper
• Involvement of hypoxia-inducible transcription factors in polycystic kidney disease.

  2007cited by this paper
• Polycystic Kidney Disease Is a Risk Factor for New-Onset Diabetes After Transplantation

  2007cited by this paper
• Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.

  2007cited by this paper
• Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.

  2006cited by this paper
• Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.

  2006cited by this paper
• Molecular pathogenesis of ADPKD: the polycystin complex gets complex.

  2005cited by this paper
• Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.

  2005cited by this paper
• Role of oxidative modifications in atherosclerosis.

  2004influential reference
• Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C.

  2002cited by this paper
• URATE HOMEOSTASIS IN POLYCYSTIC KIDNEY DISEASE: COMPARISON WITH CHRONIC GLOMERULONEPHRITIC KIDNEY

  2002cited by this paper
• Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease.

  2002cited by this paper
• Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease.

  2001cited by this paper
• Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.

  2001cited by this paper
• Citrate therapy for polycystic kidney disease in rats.

  2000cited by this paper
• High dietary fat intake increases renal cyst disease progression in Han:SPRD-cy rats.

  2000cited by this paper
• Altered expression of type II sodium/phosphate cotransporter in polycystic kidney disease.

  2000cited by this paper
• Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.

  2000cited by this paper
• Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.

  1999cited by this paper
• Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus.

  1999cited by this paper
• Insulin resistance in patients with adult polycystic kidney disease.

  1999cited by this paper
• Potassium citrate/citric acid intake improves renal function in rats with polycystic kidney disease.

  1998influential reference
• Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease.

  1998cited by this paper
• Insulin resistance in adult polycystic kidney disease.

  1997cited by this paper
• Gastric mucus of the guinea pig: proton carrier and diffusion barrier.

  1997cited by this paper
• Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.

  1997cited by this paper
• PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

  1996cited by this paper
• Erythrocyte membrane fluidity in adult polycystic kidney disease: difference between intact cells and ghost membranes

  1996cited by this paper
• The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains

  1995cited by this paper
• Abnormal effect of thiol groups on erythrocyte Na/Li countertransport kinetics in adult polycystic kidney disease.

  1995cited by this paper
• Renal stone disease in autosomal dominant polycystic kidney disease.

  1993cited by this paper
• Autosomal dominant polycystic kidney disease.

  1993cited by this paper
• A study of uric acid metabolism and gouty arthritis in patients with polycystic kidney.

  1993cited by this paper
• Autosomal dominant polycystic kidney disease

  1992cited by this paper
• Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.

  1990cited by this paper
• Hyperuricemia, gout, and autosomal dominant polycystic kidney disease.

  1989cited by this paper
• Erythropoietin in polycystic kidneys.

  1989cited by this paper
• The association of nephrolithiasis and autosomal dominant polycystic kidney disease.

  1988cited by this paper
• Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients.

  1985cited by this paper
• Tubular function in adult polycystic kidney disease.

  1979cited by this paper
• Letter: Gouty arthritis and polycystic kidney disease.

  1973cited by this paper
• ASSOCIATION OF HYPERURICEMIA AND POLYCYSTIC KIDNEY DISEASE.

  1965cited by this paper

• The Hidden Iceberg of ADPKD: Early Organomegaly-Driven Malnutrition and Sarcopenia Beyond Preserved eGFR.

  2026cites this paper
• Time-restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trial

  2025cites this paper
• A Review of the Management of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease

  2025cites this paper
• The association between serum Perilipin-2 and kidney disease progression of patients with autosomal dominant polycystic kidney disease

  2024cites this paper
• The Influence of Non-Pharmacological and Pharmacological Interventions on the Course of Autosomal Dominant Polycystic Kidney Disease

  2024cites this paper
• Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?

  2024cites this paper
• Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease.

  2023cites this paper
• Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review

  2023cites this paper
• Specific nutritional strategy is needed for good nutritional status in autosomal dominant polycystic kidney disease.

  2023cites this paper
• Autosomal Dominant Polycystic Kidney Disease Associated with Liver Cysts and Hypothyroidism: A Rare Case Finding

  2023cites this paper
• Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension

  2023cites this paper
• Urinary Citrate Is Associated with Kidney Outcomes in Early Polycystic Kidney Disease

  2022cites this paper
• Evidence of retinal arteriolar narrowing in patients with autosomal-dominant polycystic kidney disease

  2022cites this paper
• Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients

  2022cites this paper
• Evidence of retinal arteriolar narrowing in patients with autosomal-dominant polycystic kidney disease

  2022cites this paper
• Cardiac involvement in patients with Autosomal Dominant Polycystic Kidney Disease and normal renal function after six years of follow-up

  2021cites this paper
• Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD)

  2021cites this paper
• Urinary exosomes protein cargo as biomarkers of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  2020cites this paper
• Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes

  2020cites this paper
• Autosomal Dominant Polycystic Kidney Disease Is a Risk Factor for Posttransplantation Diabetes Mellitus: An Updated Systematic Review and Meta-analysis

  2020cites this paper
• Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials.

  2020cites this paper
• Predictors of Hyperuricemia after Kidney Transplantation: Association with Graft Function

  2020cites this paper
• Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease

  2020cites this paper
• Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.

  2020cites this paper
• Glycosphingolipid metabolism and polycystic kidney disease.

  2020cites this paper
• Evolution of metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease: a six-year follow-up study

  2019cites this paper
• Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course

  2019cites this paper
• Spleen phenotype in autosomal dominant polycystic kidney disease.

  2019cites this paper
• α-lipoic acid in patients with autosomal dominant polycystic kidney disease.

  2019cites this paper
• The consequences of increased 4E-BP1 in polycystic kidney disease.

  2019cites this paper
• Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease

  2019cites this paper
• Do metabolic derangements in end‐stage polycystic kidney disease differ versus other primary kidney diseases?

  2018cites this paper
• Clinical manifestations, imaging findings and laboratory abnormalities in 51 patients with autosomal dominant polycystic kidney disease: Experience at Tirupati, South India

  2018cites this paper
• Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease

  2018cites this paper
• Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.

  2018cites this paper
• Profiling conserved biological pathways in Autosomal Dominant Polycystic Kidney Disorder (ADPKD) to elucidate key transcriptomic alterations regulating cystogenesis: A cross-species meta-analysis approach.

  2017cites this paper
• A cross-platform metabolomics workflow for volume-restricted tissue samples: application to an animal model for polycystic kidney disease.

  2017cites this paper
• Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease

  2017cites this paper
• New options for the management of polycystic kidney disease

  2016cites this paper
• Autosomal dominant polycystic kidney disease: recent advances in clinical management

  2016cites this paper
• Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

  2016cites this paper
• The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease

  2015cites this paper
• An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease

  2015cites this paper
• Impact of Different Variables on Recovery Time in Patients Receiving Hemodialysis

  2015influential citation
• Autosomal dominant polycystic kidney disease: the changing face of clinical management

  2015cites this paper
• Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD

  2015cites this paper
• New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol

  2015cites this paper
• Poliquistosis renal autosómica dominante: necesidad de diagnóstico y tratamiento oportuno

  2014cites this paper
• Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease

  2014cites this paper
• Autosomal dominant polycystic kidney disease : recent advances in clinical management

  year unknowncites this paper
• Autosomal dominant polycystic kidney disease : recent advances in clinical management

  year unknowncites this paper